Telbivudine

Telbivudine is an antiviral medication used to treat chronic hepatitis B infection. It helps to reduce the amount of hepatitis B virus in the body. Telbivudine works by blocking the virus's ability to replicate, thereby reducing the amount of virus in the body. It is usually given in combination with other medications. Side effects of telbivudine may include nausea, headache, and diarrhea.

Telbivudine is an antiviral medication used to treat chronic hepatitis B infection [1, 2]. Here's a breakdown of its key features:

• Function: Telbivudine works by inhibiting the Hepatitis B virus (HBV) replication process. It's classified as a nucleoside analogue, meaning it mimics a natural building block that the virus needs to reproduce [1]. By interfering with this process, Telbivudine helps reduce the amount of virus in the body [2].
• Applications: Telbivudine is typically used for chronic hepatitis B patients with evidence of active viral replication or liver enzyme abnormalities [2]. It's not a cure for hepatitis B, but it can help control the infection and potentially reduce the risk of liver damage.
• Administration: Telbivudine is a convenient medication taken orally (by mouth) as a tablet, typically once a day with or without food [2].
• Advantages: Compared to some other hepatitis B medications, Telbivudine has been shown to be well-tolerated with a low risk of side effects [4].

Here are some additional points to consider:

• Resistance: While less common than with some other hepatitis B medications, resistance to Telbivudine can develop with prolonged use [2]. Regular monitoring is necessary to assess treatment effectiveness.
• Availability: Telbivudine was withdrawn from the US market in 2016 for economic reasons, although it may still be available in other countries under the brand names Sebivo (Europe) or Tyzeka (previously US) [5].